3648 results for «2495»
3648 results
Left main PCI
21 May 2026 – From EuroPCR 2026
This session addresses the complexities of percutaneous coronary intervention (PCI) involving the left main coronary artery. It features challenging clinical cases including acute total occlusion with cardiogenic shock, innovative techniques like the inverted Double TAP for trifurcations, mechanical circulatory support integration, management of stent complications, and...
TAVI procedural challenges
21 May 2026 – From EuroPCR 2026
This session examines procedural challenges encountered during Transcatheter Aortic Valve Implantation (TAVI), especially in complex anatomical and clinical contexts. Topics include TAVI after prior mitral valve procedures, combined use of left ventricular assist devices and rotablation, navigating challenging aortic anatomies, and managing extensive calcification. The session...
Innovative strategies in STEMI management
22 May 2026 – From EuroPCR 2026
This session presents innovative strategies in STEMI management, including the treatment of acute saphenous vein graft occlusion, primary PCI via the left internal mammary artery, and a two-step lesion debulking approach. It also covers hybrid drug-coated balloon strategies in complex multivessel disease and the emerging role...
Challenging cases in calcified lesions PCI
22 May 2026 – From EuroPCR 2026
This session addresses challenging cases in PCI of heavily calcified lesions. It covers unexpected complications such as silent shockwave failures, interventions in calcified Kawasaki disease, delayed coronary obstructions post-TAVI, and complex left main bifurcation lesions. The session underscores the perseverance required to successfully navigate these demanding...
When anatomy surprises: closing rare fistulae
21 May 2026 – From EuroPCR 2026
This session focuses on the percutaneous closure of rare and complex cardiac fistulae and related vascular anomalies. It presents diverse cases such as superior vena cava syndrome from pacemaker leads, iatrogenic aorta-to-left atrium fistula, and unusual cardio-pulmonary connections, illustrating advanced interventional techniques to address unexpected anatomical...
Diagnosis and management of INOCA and ANOCA
21 May 2026 – From EuroPCR 2026
This session focuses on the diagnosis and management of ischemia and angina with non-obstructive coronary arteries (INOCA and ANOCA). It presents safety data from coronary function testing, patient outcomes after comprehensive ischemia assessment, and endotype-specific treatment effects. Further topics include coronary sinus reducer therapy, the impact...
Calcified lesion of distal protected left main - LIVE case
22 May 2026 – From EuroPCR 2026
An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...
Prognostics elements on multivessel disease and coronary artery disease
20 May 2026 – From EuroPCR 2026
This session examines key prognostic elements in multivessel and coronary artery disease, featuring studies on mechanical circulatory support across LDL-C levels, biomarkers impacting periprocedural myocardial infarction, autologous cell therapy outcomes for refractory angina, and novel risk stratification indices. It also addresses prognosis in cancer patients and...
New evidence for coronary physiology in epicardial disease
20 May 2026 – From EuroPCR 2026
Explore new evidence in coronary physiology related to epicardial disease through analyses of landmark trials and registries. Topics include five-year follow-up data from DEFINE-FLAIR and iFR-SWEDEHEART, complete revascularization in elderly myocardial infarction patients, angiography-derived versus pressure wire assessments, prognostic implications of CT angiography-derived physiology, and the...
From entry to exit: managing arterial access for nurses and allied professionals
20 May 2026 – From EuroPCR 2026
This session focuses on arterial access management tailored for nurses and allied health professionals. It highlights key anatomical landmarks, demonstrates the purpose and use of common vascular closure devices through live manikin demonstrations, and discusses the essential role of nursing and allied staff in vascular access...
A new horizon in left main and multivessel PCI
21 May 2026 – From EuroPCR 2026
This session explores new horizons in managing left main and multivessel coronary artery disease with PCI. It covers comprehensive evaluation techniques, including physiology and imaging assessments, and advanced PCI strategies for challenging eccentric and heavily calcified lesions. Case presentations from diverse clinical contexts illustrate decision-making and...
Left main complications - Part 2
21 May 2026 – From EuroPCR 2026
This session covers intricate complications involving the left main coronary artery (LMCA), highlighting cases of catheter-induced dissections, challenges in chronic total occlusion (CTO) PCI, and rare scenarios such as stent entrapment and complex re-interventions. Emphasis is placed on the critical utility of intravascular ultrasound (IVUS) and...
CTO PCI: understand it, love it
21 May 2026 – From EuroPCR 2026
This educational session provides a comprehensive overview of chronic total occlusion (CTO) PCI, elucidating key procedural steps, essential materials, and potential complications. It highlights the significant role of nurses and allied health professionals in supporting the procedure and enhancing patient experience throughout the pre-, intra-, and...
Post myocardial infarction and iatrogenic VSDs: case-based decision taking
21 May 2026 – From EuroPCR 2026
This session focuses on decision-making in post-myocardial infarction and iatrogenic ventricular septal defects (VSDs) through illustrative cases. It covers transcatheter closure techniques, zero contrast interventions guided by echocardiography, and innovative approaches to late and residual VSDs following congenital heart surgery.
Refining the gold standard: what is new in DES
21 May 2026 – From EuroPCR 2026
This session explores recent advancements in drug-eluting stent (DES) technology, featuring global real-world evidence on short dual antiplatelet therapy (DAPT) with polymer-free DES, angiographic outcomes from pooled TARGET trials, and real-world registry data on various DES platforms. It also presents post-marketing surveillance results and systematic reviews...
Left main PCI: technical limits
21 May 2026 – From EuroPCR 2026
This comprehensive session reviews the technical challenges and current strategies in left main PCI. Topics include provisional versus DK crush approaches, IVUS-based assessment of ostial LAD lesions, long-term outcomes of DCB use in left main bifurcations, stenting strategies for complex lesions, and the prognostic value of...
Assessing coronaries in ACS with intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session highlights the critical role of intracoronary imaging in evaluating acute coronary syndromes (ACS). It discusses the management of complex lesion morphologies involving calcium and thrombus, the diagnostic power of OCT in decision-making, challenges beyond angiography in right coronary artery pathology, and the identification of...
TAVI sub-studies - Beyond the primary endpoint
21 May 2026 – From EuroPCR 2026
This session reviews key sub-studies from major TAVI trials that extend beyond primary endpoints to provide a deeper understanding of valve performance and patient outcomes. It covers comparisons between balloon-expandable and self-expanding valves, long-term real-world data on the Myval valve, echocardiographic outcomes, composite endpoint analyses, and...
Spotlight - TAVI durability: contemporary evidence and future directions
21 May 2026 – From EuroPCR 2026
Focusing on TAVI durability, this session reviews recent clinical evidence from randomized trials and large registries, examining procedural and device-related factors influencing long-term valve performance. It also discusses challenges in follow-up and implications for future trial designs and device monitoring.
New tools for risk stratification in STEMI
20 May 2026 – From EuroPCR 2026
This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.